Risk Factors of Porphyria Cutanea Tarda (PCT)

This study has been completed.
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT.

Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Porphyria Cutanea Tarda

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Longitudinal
Official Title: “Factors Associated With Porphyria Cutanea Tarda in Patients Infected With Hepatitis C Virus”

Resource links provided by NLM:

Further study details as provided by University Hospital, Strasbourg, France:

Estimated Enrollment: 280
Study Start Date: May 1999

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213772

Sponsors and Collaborators
University Hospital, Strasbourg, France
Principal Investigator: Bernard Cribier, MD Hopitaux Universitaires de Strasbourg
Principal Investigator: O. Chosidow, MD Hopital Pitié-Salpétrière / Paris
Principal Investigator: M. Bagot, MD Hopital Henri Mondor / CHU Créteil
Principal Investigator: J.P Lacour, MD Hopital de l'Archet / CHU Nice
  More Information

ClinicalTrials.gov Identifier: NCT00213772     History of Changes
Other Study ID Numbers: 2030 
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by University Hospital, Strasbourg, France:
Porphyria cutanea tarda
hepatitis C

Additional relevant MeSH terms:
Porphyria Cutanea Tarda
Porphyria, Erythropoietic
Porphyrias, Hepatic
Digestive System Diseases
Genetic Diseases, Inborn
Liver Diseases
Metabolic Diseases
Skin Diseases
Skin Diseases, Genetic

ClinicalTrials.gov processed this record on May 26, 2016